Output details

4 - Psychology, Psychiatry and Neuroscience

Output 21 of 299 in the submission

Article title

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: A randomised controlled phase 3 trial

Type

D - Journal article

DOI

Title of journal

The Lancet

Article number

Volume number

380

Issue number

9856

First page of article

1829

ISSN of journal

0140-6736

Year of publication

2012

URL

Number of additional authors

Additional information

Interdisciplinary

Cross-referral requested

Research group

None

Citation count

Proposed double-weighted

Double-weighted statement

Reserve for a double-weighted output

Non-English

English abstract